Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beasley

Showing results (351-360 of 482) with videos related to

Pageof 49
Sort By:
Annals of Surgery|July 7, 2022
Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary PracticeKristen E Rhodin, Elizabeth M Gaughan, Vignesh Raman, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depressionP J McGrath, J W Stewart, E Petkova, et al.
Annals of Surgical Oncology|February 3, 2009
Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?N McMahon, T Y Cheng, G M Beasley, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progressionMichael P Plebanek, Yue Xue, Y-Van Nguyen, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapseCharles M Beasley, Virginia K Sutton, Susan H Hamilton, et al.
Lupus|November 24, 2005
Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI)G S Alarcón, T M Beasley, J M Roseman, et al.
American Journal of Epidemiology|February 20, 2009
Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient Intake Trial to Prevent Heart DiseaseJeannette M Beasley, Brett A Ange, Cheryl A M Anderson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2015
AltitudeOmics: impaired pulmonary gas exchange efficiency and blunted ventilatory acclimatization in humans with patent foramen ovale after 16 days at 5,260 mJonathan E Elliott, Steven S Laurie, Julia P Kern, et al.
Cancer|July 29, 2009
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanomaGeorgia M Beasley, Nicole McMahon, Gretchen Sanders, et al.
Pageof 49

Showing results (351-360 of 482) with videos related to

Sort By:
Pageof 49
Annals of Surgery|July 7, 2022
Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary PracticeKristen E Rhodin, Elizabeth M Gaughan, Vignesh Raman, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depressionP J McGrath, J W Stewart, E Petkova, et al.
Annals of Surgical Oncology|February 3, 2009
Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?N McMahon, T Y Cheng, G M Beasley, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progressionMichael P Plebanek, Yue Xue, Y-Van Nguyen, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapseCharles M Beasley, Virginia K Sutton, Susan H Hamilton, et al.
Lupus|November 24, 2005
Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI)G S Alarcón, T M Beasley, J M Roseman, et al.
American Journal of Epidemiology|February 20, 2009
Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient Intake Trial to Prevent Heart DiseaseJeannette M Beasley, Brett A Ange, Cheryl A M Anderson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2015
AltitudeOmics: impaired pulmonary gas exchange efficiency and blunted ventilatory acclimatization in humans with patent foramen ovale after 16 days at 5,260 mJonathan E Elliott, Steven S Laurie, Julia P Kern, et al.
Cancer|July 29, 2009
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanomaGeorgia M Beasley, Nicole McMahon, Gretchen Sanders, et al.
Pageof 49